Stock listing
BOATS:CVM Cel-Sci Corporation Stock
US listing (BOATS) of Cel-Sci Corporation · home listing NYSE American:CVM
Follow Cel-Sci Corporation into a list and get an email when it puts out news.
Home listing price · AMEX:CVM
$1.21 USD -0.26 (-17.7%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:CVM
- Day range
- $1.19 – $1.59 USDNov 20, 2026
- Volume
- 879,700 sharesNov 20, 2026
- Market cap
- $21.28M USDAt the close on Nov 20, 2026 · price × 17.59M shares outstanding
- 52-week range
- $0.89 – $7.80 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $401,527 USDMedian day 129,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:CVM · Home | $1.21 USD | -0.26 (-17.7%) | 879,700 | $1.535 | $1.59 | $1.185 | $1.47 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · AMEX:CVM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.21 | -0.26 | -17.7% | $1.535 | $1.59 | $1.185 | 879,700 | |
| $1.47 | +0.09 | +6.5% | $1.46 | $1.51 | $1.38 | 263,400 | |
| $1.38 | -0.47 | -25.4% | $1.70 | $1.71 | $1.34 | 613,600 | |
| $1.85 | +0.19 | +11.4% | $1.86 | $2.14 | $1.73 | 1,482,800 | |
| $1.66 | +0.38 | +29.7% | $1.32 | $1.75 | $1.30 | 1,163,200 | |
| $1.28 | +0.09 | +7.6% | $1.19 | $1.28 | $1.15 | 145,700 | |
| $1.19 | -0.12 | -9.2% | $1.33 | $1.35 | $1.19 | 150,000 | |
| $1.31 | -0.10 | -7.1% | $1.41 | $1.43 | $1.28 | 88,000 | |
| $1.41 | +0.06 | +4.4% | $1.44 | $1.50 | $1.33 | 128,500 | |
| $1.35 | -0.10 | -6.9% | $1.45 | $1.53 | $1.35 | 53,800 | |
| $1.45 | +0.08 | +5.8% | $1.37 | $1.45 | $1.34 | 46,700 | |
| $1.37 | -0.01 | -0.7% | $1.39 | $1.43 | $1.28 | 97,800 | |
| $1.38 | -0.03 | -2.1% | $1.41 | $1.46 | $1.38 | 27,800 | |
| $1.41 | +0.10 | +7.6% | $1.31 | $1.41 | $1.24 | 215,400 | |
| $1.31 | -0.07 | -5.1% | $1.39 | $1.44 | $1.30 | 91,900 | |
| $1.38 | -0.12 | -8.0% | $1.49 | $1.49 | $1.36 | 189,100 | |
| $1.50 | -0.10 | -6.3% | $1.56 | $1.64 | $1.50 | 77,900 | |
| $1.60 | +0.03 | +1.9% | $1.54 | $1.62 | $1.52 | 98,400 | |
| $1.57 | -0.02 | -1.3% | $1.58 | $1.60 | $1.46 | 117,600 | |
| $1.59 | -0.05 | -3.0% | $1.71 | $1.83 | $1.51 | 106,900 | |
| $1.64 | +0.03 | +1.9% | $1.59 | $1.64 | $1.57 | 41,900 | |
| $1.61 | -0.01 | -0.6% | $1.61 | $1.65 | $1.58 | 78,500 | |
| $1.62 | +0.07 | +4.5% | $1.56 | $1.62 | $1.50 | 149,400 | |
| $1.55 | -0.10 | -6.1% | $1.65 | $1.66 | $1.54 | 140,500 | |
| $1.65 | -0.14 | -7.8% | $1.79 | $1.81 | $1.60 | 129,900 | |
| $1.79 | +0.05 | +2.9% | $1.78 | $1.93 | $1.75 | 168,200 | |
| $1.74 | +0.03 | +1.8% | $1.69 | $1.78 | $1.66 | 72,000 | |
| $1.71 | -0.04 | -2.3% | $1.73 | $1.75 | $1.68 | 105,700 | |
| $1.75 | -0.08 | -4.4% | $1.84 | $1.84 | $1.71 | 224,600 | |
| $1.83 | -0.11 | -5.7% | $1.95 | $1.97 | $1.76 | 357,200 | |
| $1.94 | -0.01 | -0.5% | $1.96 | $1.98 | $1.83 | 255,400 | |
| $1.95 | -0.18 | -8.5% | $2.10 | $2.25 | $1.92 | 385,500 | |
| $2.13 | -0.61 | -22.3% | $2.74 | $2.77 | $2.07 | 661,100 | |
| $2.74 | +0.32 | +13.2% | $2.42 | $2.83 | $2.29 | 470,100 | |
| $2.42 | +0.11 | +4.8% | $2.39 | $2.75 | $2.35 | 796,100 | |
| $2.31 | +0.22 | +10.5% | $2.14 | $2.31 | $2.03 | 387,500 | |
| $2.09 | +0.03 | +1.5% | $2.06 | $2.30 | $1.96 | 807,600 | |
| $2.06 | +0.27 | +15.1% | $1.80 | $2.09 | $1.78 | 474,000 | |
| $1.79 | +0.09 | +5.3% | $1.70 | $1.79 | $1.70 | 74,500 | |
| $1.70 | +0.03 | +1.8% | $1.67 | $1.72 | $1.67 | 126,200 | |
| $1.67 | -0.05 | -2.9% | $1.70 | $1.71 | $1.67 | 36,400 | |
| $1.72 | +0.04 | +2.4% | $1.70 | $1.76 | $1.68 | 56,100 | |
| $1.68 | -0.02 | -1.2% | $1.69 | $1.76 | $1.68 | 171,400 | |
| $1.70 | +0.03 | +1.8% | $1.70 | $1.73 | $1.66 | 133,800 | |
| $1.67 | +0.01 | +0.6% | $1.71 | $1.75 | $1.66 | 109,600 | |
| $1.66 | +0.17 | +11.4% | $1.53 | $1.70 | $1.51 | 265,000 | |
| $1.49 | +0.01 | +0.7% | $1.51 | $1.57 | $1.49 | 43,200 | |
| $1.48 | 0.00 | 0.0% | $1.50 | $1.53 | $1.47 | 71,400 | |
| $1.48 | -0.04 | -2.6% | $1.53 | $1.54 | $1.47 | 94,700 | |
| $1.52 | +0.03 | +2.0% | $1.46 | $1.56 | $1.46 | 66,500 | |
| $1.49 | -0.03 | -2.0% | $1.55 | $1.55 | $1.46 | 98,500 | |
| $1.52 | -0.02 | -1.3% | $1.57 | $1.58 | $1.51 | 75,900 | |
| $1.54 | -0.11 | -6.7% | $1.67 | $1.67 | $1.54 | 85,800 | |
| $1.65 | +0.02 | +1.2% | $1.64 | $1.77 | $1.64 | 283,300 | |
| $1.63 | +0.02 | +1.2% | $1.61 | $1.63 | $1.58 | 75,100 | |
| $1.61 | -0.04 | -2.4% | $1.65 | $1.68 | $1.60 | 116,100 | |
| $1.65 | +0.04 | +2.5% | $1.64 | $1.70 | $1.60 | 134,100 | |
| $1.61 | -0.01 | -0.6% | $1.60 | $1.63 | $1.57 | 70,000 | |
| $1.62 | +0.06 | +3.8% | $1.59 | $1.62 | $1.54 | 55,700 | |
| $1.56 | -0.04 | -2.5% | $1.61 | $1.61 | $1.53 | 169,400 | |
| $1.60 | -0.01 | -0.6% | $1.60 | $1.69 | $1.57 | 161,000 | |
| $1.61 | +0.13 | +8.8% | $1.55 | $1.70 | $1.53 | 262,300 | |
| $1.48 | +0.10 | +7.2% | $1.40 | $1.50 | $1.37 | 86,400 | |
| $1.38 | -0.04 | -2.8% | $1.42 | $1.43 | $1.34 | 147,700 | |
| $1.42 | -0.04 | -2.7% | $1.48 | $1.49 | $1.42 | 66,100 | |
| $1.46 | -0.18 | -11.0% | $1.62 | $1.64 | $1.45 | 183,500 |
Splits
4 splits since 1995 · AMEX:CVM · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-30 | Consolidation | |
| 1-for-25 | Consolidation | |
| 1-for-10 | Consolidation | |
| 1-for-10 | Consolidation |
- Ticker
- BOATS:CVM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 20, 2026
CEL-SCI’s Multikine® Receives Saudi FDA NADR Designation, Accelerating Potential Commercial Launch
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 22 slides
Latest news
CEL-SCI’s Multikine® Receives Saudi FDA NADR Designation, Accelerating Potential Commercial Launch
Nov 20, 2026
Closed $1.21 (-17.7%) on Nov 20, 2026
CEL-SCI’s Dr. Eyal Talor Receives Second International Keynote Invitation on Multikine Head and Neck Cancer Research
Nov 10, 2026
Closed $1.41 (+4.4%) on Nov 10, 2026
CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
Oct 26, 2026
Closed $1.59 (-3.0%) on Oct 26, 2026
CEL-SCI Reports Fiscal Third Quarter 2026 Results
Aug 17, 2026
Closed $1.55 (+0.6%) on Aug 17, 2026
Cel-Sci: Fiscal Q3 Earnings Snapshot
Aug 14, 2026
Closed $1.55 (+0.6%) on Aug 17, 2026
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
Jul 13, 2026
Closed $1.22 (-11.6%) on Jul 13, 2026
CEL-SCI Announces Closing of Offering
Jun 16, 2026
Closed $1.10 (+8.9%) on Jun 17, 2026
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Jun 16, 2026
Closed $1.01 (0.0%) on Jun 16, 2026
CEL-SCI Corporation Announces Pricing of Offering
Jun 14, 2026
Closed $1.01 (-6.5%) on Jun 15, 2026
CEL-SCI Reports Fiscal Second Quarter 2026 Results
May 18, 2026
Closed $1.72 (+20.3%) on May 18, 2026
Cel-Sci Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 32 in all · newest Nov 20, 2026 · oldest 2025
- Decks
- 57 decks · latest November 2026
Where Cel-Sci Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:CVM · Home listing | NYSE American | United States | USD |
| gettex:LSR | gettex | Germany | EUR |
| BOATS:CVM · This page | BOATS | United States | USD |
| Munich:LSR | Munich | Germany | EUR |
| Frankfurt:LSR | Frankfurt | Germany | EUR |
| Lang & Schwarz:A418TV | Lang & Schwarz | Germany | EUR |
| LS Exchange:A418TV | LS Exchange | Germany | EUR |
Valuation
Price/book 1.9× against a median of 1.7×: 5th lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $14.76M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.9×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.13
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cel-Sci Corporation · AMEX:CVM | US$21.28M | US$14.76M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | 1.13 |
| ME Therapeutics Holdings, Inc. · CSE:METX | US$22.25M | US$21.88M | n/a | n/a | n/a | 49.5× | n/a | 0.0× | 0.52 |
| CervoMed Inc. · NASDAQ:CRVO | US$22.09M | US$2.49M | n/a | 285× | n/a | 1.3× | n/a | 0.0× | 1.97 |
| Sona Nanotech, Inc. · CSE:SONA | US$21.84M | US$22.06M | n/a | n/a | n/a | n/a | n/a | n/a | 0.47 |
| Mendus AB · OMXSTO:IMMU | US$21.73M | US$17.63M | n/a | n/a | n/a | 0.4× | n/a | 0.0× | n/a |
| Metagenomi Therapeutics, Inc. · NASDAQ:MGX | US$21.36M | −US$44.10M | n/a | −6.2× | n/a | 0.2× | n/a | 0.4× | 1.65 |
| NanoGroup SA · GPW:NNG | US$21.31M | US$18.78M | n/a | n/a | n/a | 4.0× | n/a | 0.0× | n/a |
| ZYUS Life Sciences Corporation · TSXV:ZYUS | US$20.92M | US$25.65M | n/a | 98.4× | n/a | n/a | n/a | n/a | -0.02 |
| Xbrane Biopharma AB · OMXSTO:XBRANE | US$20.86M | US$23.45M | n/a | 1.9× | n/a | 0.4× | −49.0% | 0.1× | n/a |
| Vivoryon Therapeutics N.V. · EURONEXT:VVY | US$20.48M | US$17.77M | n/a | n/a | n/a | 11.9× | n/a | 0.1× | n/a |
| Evaxion A/S · NASDAQ:EVAX | US$20.30M | US$13.40M | n/a | 1.8× | n/a | 2.1× | −115.1% | 0.8× | 0.78 |
| Median of the others | US$21.34M | US$18.27M | 1.9× | 1.7× | −82.1% | 0.0× | 0.65 |
Forecasts
1 strong buy · Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 12.50 USD · Analysts' mean
- EPS, year to Sep 2026
- -3.07 · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Geert R. Kersten | Director and Chief Executive Officer |
| Patricia B. Prichep | Chief Financial and Operations Officer |
| John Cipriano | Senior Vice President of Regulatory Affairs |
| Tracey R. Kessler | Vice President of Product Development and Manufacturing Operations |
| Eyal Talor | Chief Scientific Officer |
Board
| Director | Role |
|---|---|
| Bruno Baillavoine | Chairman of the Board |
| Geert R. Kersten | Director and Chief Executive Officer |
| Robert Watson | Director |
Events
- Next results
- Jan 4, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Aug 14, 2026 | +4.0% |
| Q1 2026 | Feb 12, 2026 · Before open | −5.3% |
| Q4 2025 | Dec 23, 2025 · After close | +5.4% |
| Q3 2025 | Aug 12, 2025 · After close | +9.4% |
| Q2 2025 | May 13, 2025 · After close | −7.7% |
| Q1 2025 | Jan 13, 2025 · After close | −2.4% |
| Q4 2024 | Dec 31, 2024 | 0.0% |
| Q3 2024 | Aug 14, 2024 · After close | −0.9% |
| Q2 2024 | May 15, 2024 · After close | −2.8% |
| Q1 2024 | Feb 14, 2024 · After close | −0.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Dec 21, 2023 · After close | +3.0% |
| Q3 2023 | Aug 11, 2023 · Before open | −12.7% |
| Q2 2023 | May 12, 2023 · After close | +8.3% |
| Q1 2023 | Feb 14, 2023 · After close | −0.4% |
| Q4 2022 | Dec 27, 2022 · After close | +9.2% |
| Q3 2022 | Aug 12, 2022 · After close | +25.4% |
| Q2 2022 | May 13, 2022 · After close | +2.8% |
| Q1 2022 | Feb 11, 2022 · After close | −3.9% |
| Q4 2021 | Dec 21, 2021 · After close | +3.3% |
| Quarter to Jun 30, 2021 | Aug 13, 2021 · After close | +0.3% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (November 2026) | Investor deck | 22 slides | November 2026 |
| Investor Presentation (September 2026) | Investor deck | 21 slides | September 2026 |
| Investor Presentation (September 2026) | Investor deck | 22 slides | September 2026 |
| Investor Presentation (August 2026) | Investor deck | 22 slides | August 2026 |
| Investor Presentation (July 2026) | Investor deck | 21 slides | July 2026 |
| Investor Presentation (May 2026) | Investor deck | 23 slides | May 2026 |
| Investor Presentation (May 2026) | Investor deck | 22 slides | May 2026 |
| Investor Presentation (November 2025) | Investor deck | 22 slides | November 2025 |
| Investor Presentation (September 2025) | Investor deck | 18 slides | September 2025 |
| Investor Presentation (August 2025) | Investor deck | 18 slides | August 2025 |
Show 50 decks
This page holds 50 of 57 decks. Open Decks
Financings
| Raise | Date |
|---|---|
| Registered direct offering of shares of common stock Closed: US$2.5M raised · US$1 a share · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Continued development of Multikine, general corporate purposes and working capital | Jun 16, 2026 |
| Public offering of common stock Closed: US$10M raised · US$9 a share · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Continued development of Multikine, general corporate purposes and working capital | Aug 29, 2025 |
| Registered direct offering of common stock Closed: US$5.7M raised · US$3.82 a share · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Continued development of Multikine, general corporate purposes and working capital | Jul 14, 2025 |
| Public offering of common stock Closed: US$5M raised · US$2.5 a share · ThinkEquity Dealers: ThinkEquity (lead) Use of proceeds: Continued development of Multikine, general corporate purposes and working capital | May 23, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | 15.9M | 18.2M | 22.5M | 25.4M | 23.1M | 17.8M | 12.7M | 10.9M | 15.6M | 17.4M |
| Operating income | -24.8M | -26.4M | -31.5M | -36.1M | -36.2M | -29.0M | -20.2M | -16.8M | -21.4M | -23.6M |
| Depreciation and amortization | 2.06M | 2.13M | 2.11M | 1.98M | 447.0K | 389.0K | 588.0K | 575.0K | 593.0K | 626.0K |
| EBITDA | -22.8M | -24.2M | -29.4M | -34.1M | -35.7M | -28.6M | -19.6M | -16.2M | -20.8M | -23.0M |
| Interest expense | 649.0K | 746.0K | 675.4K | 1.08M | 1.20M | |||||
| Income before tax | -30.3M | -22.1M | ||||||||
| Net income | -25.4M | -26.9M | -32.4M | -36.7M | -36.4M | -30.3M | -22.1M | -31.8M | -14.4M | -11.5M |
| Earnings per share, basic | -3.17 | -12.66 | -0.68 | -0.87 | -0.90 | -0.82 | -0.71 | -1.87 | -1.83 | -2.37 |
| Earnings per share, diluted | -6.27 | -15.31 | -0.73 | -0.87 | -0.90 | -0.82 | -0.71 | -1.87 | -1.91 | -2.37 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.0M | 4.74M | 4.15M | 22.7M | 36.1M | 15.5M | 8.44M | 10.3M | 2.37M | 2.92M |
| Short-term investments | 0 | 6.15M | 0 | |||||||
| Receivables | 0 | 54.9K | 54.9K | 62.8K | 118.7K | 218.5K | 394.5K | |||
| Inventory | 1.02M | 2.25M | 2.00M | 2.01M | 820.1K | 782.4K | 645.2K | 672.5K | 1.01M | |
| Current assets | 11.6M | 6.06M | 6.92M | 25.4M | 45.3M | 17.7M | 9.81M | 11.4M | 4.24M | 5.46M |
| Property, plant and equipment | 6.08M | 8.13M | 10.2M | 11.9M | 13.7M | 5.84M | 15.8M | 16.2M | 16.8M | 17.4M |
| Total assets | 28.2M | 27.0M | 30.5M | 50.5M | 75.9M | 40.5M | 27.6M | 29.6M | 22.9M | 24.9M |
| Accounts payable | 1.06M | 1.45M | 2.01M | 1.62M | 1.68M | 2.02M | 1.59M | 5.74M | 8.20M | 3.09M |
| Current liabilities | 5.13M | 4.62M | 5.59M | 4.66M | 3.94M | 4.27M | 3.02M | 9.23M | 10.8M | 4.01M |
| Long-term debt | 5.68M | |||||||||
| Total debt | 2.27M | |||||||||
| Total liabilities | 12.2M | 14.1M | 17.3M | 18.4M | 19.3M | 20.8M | 22.5M | 29.6M | 26.3M | 25.6M |
| Shareholders' equity | 16.0M | 12.9M | 13.2M | 32.2M | 56.5M | 19.7M | 5.13M | 916 | -3.34M | -679.2K |
| Shares outstanding | 8.02M | 2.13M | 47.4M | 43.4M | 43.2M | 38.7M | 35.2M | 28.0M | 11.9M | 6.25M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -17.1M | -18.8M | -22.8M | -18.2M | -18.8M | -15.3M | -16.3M | -13.4M | -13.8M | -23.1M |
| Capital spending | -38.1K | -94.9K | -361.9K | -637.9K | -9.02M | -2.65M | -177.8K | -1.01K | -10.5K | -31.4K |
| Free cash flow | -17.2M | -18.9M | -23.2M | -18.9M | -27.8M | -17.9M | -16.5M | -13.4M | -13.8M | -23.1M |
| Cash from investing | -38.1K | -108.1K | -372.3K | 5.49M | -15.2M | -2.69M | -335.8K | -58.1K | -17.0K | -34.2K |
| Cash from financing | 23.4M | 19.5M | 4.69M | -638.4K | 54.5M | 25.0M | 14.8M | 21.4M | 13.3M | 20.3M |
| Change in cash | 6.22M | 592.4K | -18.5M | -13.4M | 20.6M | 7.06M | -1.87M | 7.94M | -548.6K | -2.81M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 19, 2026 | Current report | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Sep 3, 2026 | Offer document | SEC |
| 4 · Change in ownership | Aug 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 17, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 17, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Jul 2, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Jul 2, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 16, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Jun 15, 2026 | Offer document | SEC |
| RW · Request to withdraw a registration | May 27, 2026 | Other filings | SEC |
| RW · Request to withdraw a registration | May 18, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 14, 2026 | Material contract | SEC |
| 4 · Change in ownership | May 14, 2026 | Insider trade | SEC |
| 8-K · Current report | May 13, 2026 | Material contract | SEC |
| 424B4 · Prospectus | May 12, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 12, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 7, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 7, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 7, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 7, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 1, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 1, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 1, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 1, 2026 | Offer document | SEC |
| DEL AM | Apr 24, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 20, 2026 | Other filings | SEC |
| S-1 · Registration statement | Apr 17, 2026 | Offer document | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Feb 17, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Jan 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 10-K · Annual report | Dec 23, 2025 | Annual report | SEC |
| 4 · Change in ownership | Dec 5, 2025 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Dec 4, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 1, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 24, 2025 | Current report | SEC |
| S-3 · Registration statement | Nov 7, 2025 | Offer document | SEC |
| 8-K · Current report | Nov 5, 2025 | Current report | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 2, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 29, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 29, 2025 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 29, 2025 | Big-stake notice | SEC |
| 424B5 · Prospectus | Aug 28, 2025 | Offer document | SEC |
| 424B5 · Prospectus | Aug 27, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 22, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Aug 13, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 7, 2025 | Other filings | SEC |
| S-3/A · Registration statement, amended | Aug 5, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Aug 5, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 30, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 28, 2025 | Insider trade | SEC |
| DRS · Draft registration statement | Jul 24, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jul 15, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 14, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Jul 11, 2025 | Offer document | SEC |
| S-3 · Registration statement | Jul 3, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2025 | Insider trade | SEC |
| 8-K · Current report | May 23, 2025 | Material contract | SEC |
| 424B5 · Prospectus | May 22, 2025 | Offer document | SEC |
| 424B5 · Prospectus | May 21, 2025 | Offer document | SEC |
| 8-K · Current report | May 19, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 14, 2025 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Apr 9, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 9, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| PRE 14A · Preliminary proxy statement | Mar 21, 2025 | Meeting notice | SEC |
| 8-K · Current report | Mar 18, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Mar 18, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Mar 12, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 3, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Feb 24, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Feb 14, 2025 | Quarterly report | SEC |
| 10-K · Annual report | Jan 13, 2025 | Annual report | SEC |
| 424B3 · Prospectus | Jan 3, 2025 | Offer document | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 31, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Dec 30, 2024 | Offer document | SEC |
| NT 10-K · Late filing notice | Dec 30, 2024 | Explanation request | SEC |
| 424B5 · Prospectus | Dec 27, 2024 | Offer document | SEC |
| 8-K · Current report | Nov 15, 2024 | Management or board change | SEC |
| 8-K · Current report | Nov 13, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Nov 8, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 5, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 4, 2024 | Other filings | SEC |
| S-3/A · Registration statement, amended | Oct 30, 2024 | Offer document | SEC |
| S-3 · Registration statement | Oct 25, 2024 | Offer document | SEC |
| POS AM · Amendment to an effective registration | Oct 11, 2024 | Offer document | SEC |
| AW | Oct 10, 2024 | Other filings | SEC |
| S-3/A · Registration statement, amended | Oct 8, 2024 | Offer document | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 16, 2024 | Current report | SEC |
| S-8 · Registration statement for employee plans | Aug 30, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Jul 29, 2024 | Offer document | SEC |
| 8-K · Current report | Jul 26, 2024 | Current report | SEC |
| 4 · Change in ownership | Jul 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 1, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 18, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 23, 2024 | Insider trade | SEC |
| 8-K · Current report | Apr 23, 2024 | Management or board change | SEC |
| 8-K · Current report | Apr 19, 2024 | Meeting outcome | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2024 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Mar 7, 2024 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Mar 7, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Mar 7, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | Feb 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Feb 13, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Feb 9, 2024 | Offer document | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Dec 22, 2023 | Offer document | SEC |
| 10-K · Annual report | Dec 21, 2023 | Annual report | SEC |
| 8-K · Current report | Nov 20, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Nov 16, 2023 | Offer document | SEC |
| 8-K · Current report | Oct 30, 2023 | Material contract | SEC |
| 8-K · Current report | Oct 24, 2023 | Current report | SEC |
| 4 · Change in ownership | Oct 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 3, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 31, 2023 | Material contract | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 10, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jul 20, 2023 | Current report | SEC |
| 424B5 · Prospectus | Jul 18, 2023 | Offer document | SEC |
| 8-K · Current report | Jul 18, 2023 | Material contract | SEC |
| FWP · Free writing prospectus | Jul 17, 2023 | Offer document | SEC |
| 424B5 · Prospectus | Jul 17, 2023 | Offer document | SEC |
| 8-K · Current report | Jul 14, 2023 | Current report | SEC |
| 8-K · Current report | Jul 12, 2023 | Current report | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 3, 2023 | Insider trade | SEC |
| 8-K · Current report | May 23, 2023 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 2, 2023 | Current report | SEC |
| 8-K · Current report | May 1, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Apr 28, 2023 | Offer document | SEC |
| 8-K · Current report | Apr 19, 2023 | Current report | SEC |
| DEFA14A · Additional proxy material | Apr 10, 2023 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Apr 10, 2023 | Annual report | SEC |
| DEF 14A · Proxy statement | Apr 10, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 6, 2023 | Insider trade | SEC |
This page holds 200 of 1,008 filings. Open Filings
Cap table
Built by 6ix from Cel-Sci Corporation’s releases · as of Aug 10, 2026
- Common shares
- 17,588,987
- Fully diluted
- 17,588,987
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 17,588,987 | Aug 10, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 10, 2026 | 17,588,987 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Gail K. Naughton Other companies: TherapeuticsMD, Inc. (Board Member · Since at least Mar 20, 2020); Histogen Inc (See Remarks · May 26, 2020 – Jan 13, 2021 · Past) | Director · Aug 2, 2022 – Aug 8, 2023 · Past |
| Mario Gobbo Other companies: Cryomass Technologies Inc. (Director · Feb 18, 2022 – May 16, 2023 · Past) | Director · Apr 19, 2024 – Apr 19, 2024 · Past |
| Bruno Baillavoine | Chairman of the Board · Since at least Jun 22, 2015 |
| Eyal Talor | Chief Scientific Officer · Since at least Sep 30, 2020 |
| Gavin de Windt | For Investor Relations · Aug 29, 2025 – Nov 4, 2026 · Past |
| Geert R. Kersten | Director and Chief Executive Officer · Since at least Jun 13, 2022 |
| John Cipriano | Senior Vice President of Regulatory Affairs · Since at least Nov 5, 2026 |
| Patricia B. Prichep | Chief Financial and Operations Officer · Since at least Mar 29, 2013 |
| Robert Watson | Director · Since at least Jun 13, 2022 |
| Tracey R. Kessler | Vice President of Product Development and Manufacturing Operations · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Cel-Sci Corporation.